Review ofa Case of Coexisting KRAS and BRAF Mutations in a Patient with Metastatic Colon Adenocarcinoma
Innovations in Medicine and Medical Research Vol. 2,
Page 134-141
Abstract
KRAS and BRAF mutations are found in 30-50% and 10% of metastatic colorectal cancer (mCRC) patients respectively. Here we report a unique case of mCRC with coexistent KRAS and BRAF mutations. Patients harboring concomitant KRAS and BRAF mutations do not usually respond to standard chemotherapeutic regimens, usually have aggressive course of illness with poor prognosis and we are in dire need of developing new treatment strategies.
Keywords:
- Colorectal cancer
- KRAS
- BRAF
How to Cite
Vittal, A., Middinti, A., & Kasi, A. (2020). Review ofa Case of Coexisting KRAS and BRAF Mutations in a Patient with Metastatic Colon Adenocarcinoma. Innovations in Medicine and Medical Research Vol. 2, 134-141. Retrieved from https://stm1.bookpi.org/index.php/immr-v2/article/view/1220
- Abstract View: 0 times